Edwards Pascal Precision Transcatheter Mitral And Tricuspid Valve Repair System Receives CE Mark
On August 17, 2022, Edwards Lifesciences Corporation, an American medical technology company headquartered in Irvine, California, specializes in artificial heart valves and hemodynamic monitoring. The company announced that it has received CE mark approval for its PASCAL Precision transcatheter valve repair system for the treatment of mitral and tricuspid regurgitation (MR and TR).
Through a single delivery system, the PASCAL Precision system is used to treat patients with mitral or tricuspid regurgitation. The new system is made to allow for precise navigation and d...
